Product Code: ETC362364 | Publication Date: Aug 2022 | Product Type: Market Research Report | |
Publisher: 6Wresearch | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
The India butterfly needle sets market import shipments experienced robust growth from 2020 to 2024, with a notable CAGR of 8.8%. Momentum accelerated significantly between 2023 and 2024, with a remarkable growth rate of 251.9%. The market expanded steadily, showing a strong upward trend over the period.
The India butterfly needle sets market size was worth US$ 271 million and anticipated to witness significant gains owing its widespread usage across pharmaceutical units , hospitals & research institutes due its single use attributes that eliminates risks pertaining contamination upon reuse alongside robust safety features included within these needles helping avoid accidental pricking while drawing out fluids from patients body but instead smoothly piercing through skin without causing any harm. Growing focus towards installation or upgradation on existing infrastructural essentials including purchase on latest medical devices will drive product demand considerably especially when considering multiple advantages they carry like precision oriented operations along reduced pain sensation while injecting liquids inside human body precisely enhancing durability factor linked associated elements thus making them favorable option among end users.
The India butterfly needle sets market is witnessing robust growth due to several drivers. One of the key drivers is the increasing prevalence of chronic diseases, which necessitates frequent blood draws and intravenous (IV) therapies. Butterfly needle sets offer a less painful and efficient way to collect blood samples and administer medications through IV access. Additionally, the rising number of healthcare facilities and medical laboratories in India has led to a higher demand for reliable and user-friendly blood collection devices, contributing to the growth of the butterfly needle sets market. Moreover, the growing awareness about infection control measures and the need for safer medical procedures have driven the adoption of safety-engineered butterfly needle sets that help reduce the risk of needlestick injuries among healthcare professionals. Furthermore, the emphasis on patient comfort and experience in healthcare settings has led to the preference for butterfly needle sets, as they offer less discomfort during blood collection or IV therapy. As the healthcare industry continues to prioritize patient safety and convenience, the demand for butterfly needle sets is expected to witness steady growth in India.
The India butterfly needle sets market faces several challenges in delivering safe and effective venipuncture and intravenous access to patients. One of the key challenges is the lack of awareness and training among healthcare professionals about the proper use and insertion technique of butterfly needle sets. Improper usage can lead to complications, such as hematoma, phlebitis, and accidental needlestick injuries. Additionally, the availability of counterfeit and substandard butterfly needle sets in the market poses a significant risk to patient safety. Ensuring the quality and regulatory compliance of these medical devices is essential to prevent adverse events and improve patient outcomes. Moreover, the high cost of some butterfly needle sets can be a deterrent for healthcare facilities with limited budgets, potentially leading to the use of inferior and unsafe alternatives. Standardizing the procurement and usage of butterfly needle sets in healthcare facilities can help mitigate these challenges and ensure consistent and safe practices. Furthermore, optimizing the design and usability of butterfly needle sets, considering patient comfort and healthcare professional ergonomics, can enhance the overall patient experience and adherence to the procedure. Addressing these challenges requires collaboration between regulatory authorities, manufacturers, and healthcare institutions to ensure the availability of high-quality and affordable butterfly needle sets, while providing continuous training and education to healthcare professionals for safe and proficient use.
The India butterfly needle sets market experienced mixed impacts during the COVID-19 pandemic. The demand for butterfly needle sets used for venipuncture and intravenous procedures surged in hospitals treating COVID-19 patients, where timely and efficient blood collection was crucial. However, in other healthcare settings, elective procedures and routine blood tests were deferred, affecting the demand for these devices. The disruption in the supply chain and logistic challenges also posed obstacles for manufacturers and distributors. Nevertheless, as routine healthcare services resume, and with an increased focus on infection control measures, the market for butterfly needle sets is expected to witness recovery and sustained growth in the post-pandemic era.
In the India butterfly needle sets market, several key players are involved in the manufacturing and supply of butterfly needles used for venipuncture and intravenous (IV) access. Romsons International is a prominent player known for its range of butterfly needles with advanced safety features and patient comfort in mind. They cater to hospitals, nursing homes, and healthcare settings. Nipro India Corporation Pvt. Ltd. is another major player offering butterfly needle sets that are designed for smooth and painless venipuncture. They focus on providing high-quality medical devices to healthcare professionals. Additionally, BD India Pvt. Ltd. is a key player in the market, providing butterfly needle sets with advanced safety mechanisms to prevent needlestick injuries. These key players actively collaborate with healthcare organizations, infection control teams, and regulatory authorities to promote safe and effective venipuncture practices. Their dedication to quality, patient safety, and infection control has established them as influential players in the India butterfly needle sets market.